gemcitabine has been researched along with Bile Duct Obstruction in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bartels, A; Bolch, M; Branchi, V; Dold, L; Gonzalez-Carmona, MA; Heling, DJ; Kaczmarek, DJ; Kalff, JC; Mahn, R; Manekeller, S; Matthaei, H; Mohr, RU; Möhring, C; Nattermann, J; Sadeghlar, F; Strassburg, CP; Vogt, A; Weismüller, TJ; Zhou, T | 1 |
| Ibusuki, M; Inoue, T; Ito, K; Kitano, R; Kobayashi, Y; Naitoh, I; Nakade, Y; Sumida, Y; Yoneda, M | 1 |
| Bahra, M; Denecke, T; Jühling, A; Klein, F; Pelzer, U; Riess, H; Roemmler-Zehrer, J; Sinn, M; Striefler, J; Wislocka, L | 1 |
| Arizumi, T; Hirano, K; Isayama, H; Ito, Y; Kawabe, T; Kogure, H; Matsubara, S; Nakai, Y; Omata, M; Sasahira, N; Sasaki, T; Tada, M; Togawa, O; Tsujino, T; Yagioka, H; Yoshida, H | 1 |
| Ishiguro, M; Kamio, Y; Mori, N; Murakami, T; Shimomukai, Y; Yokooji, T | 1 |
| Kulke, MH | 1 |
| Aerts, R; Haustermans, K; Topal, B; Van Cutsem, E; Van Steenbergen, W; Verslype, C | 1 |
| Fujihara, M; Fujita, M; Furukawa, Y; Hattori, Y; Ishii, Y; Kuniki, H; Matsumoto, N; Yajima, T; Yamamoto, M; Yamaoka, Y | 1 |
| Fuchs, M; Schepp, W | 1 |
| Arnoletti, JP; Ben-Josef, E; Bhargava, P; Casper, ES; Kim, P; Malafa, MP; Nakakura, EK; Shibata, S; Talamonti, M; Tempero, M; Wang, H; Willett, C | 1 |
| Alberts, SR; Jacobson, SD; O'Connell, MJ | 1 |
4 review(s) available for gemcitabine and Bile Duct Obstruction
| Article | Year |
|---|---|
Metastatic pancreatic cancer.
Topics: Antineoplastic Agents; Autonomic Nerve Block; Celiac Plexus; Cholestasis; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Digestive System Diseases; Fluorouracil; Gastric Outlet Obstruction; Gemcitabine; Humans; Neoplasm Metastasis; Neuralgia; Palliative Care; Pancreatic Neoplasms; Risk Factors; Stents | 2002 |
Systemic treatment of pancreatic cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Duodenal Obstruction; Gemcitabine; Humans; Neoplasm Recurrence, Local; Palliative Care; Pancreatic Neoplasms; Postoperative Care; Treatment Outcome | 2004 |
Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
Topics: Adenocarcinoma; Algorithms; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cholestasis; Deoxycytidine; Disease Management; Drainage; Gastric Outlet Obstruction; Gemcitabine; Humans; Lymph Node Excision; Neoplasm Staging; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Portal Vein; Radiotherapy, Adjuvant; Treatment Outcome | 2007 |
Pancreatic cancer in the older patient.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Cholestasis; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Pain; Pain Management; Palliative Care; Pancreatic Neoplasms | 2001 |
7 other study(ies) available for gemcitabine and Bile Duct Obstruction
| Article | Year |
|---|---|
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis; Cholestasis; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Radiofrequency Ablation; Retrospective Studies; Survival Rate; Treatment Outcome | 2022 |
Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholestasis; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Radiofrequency Ablation; Retrospective Studies; Treatment Outcome | 2022 |
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Databases, Factual; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Hyperbilirubinemia; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biliary Tract Surgical Procedures; Cholangitis; Cholecystitis; Cholestasis; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Neutropenia; Palliative Care; Pancreatic Neoplasms; Prosthesis Design; Prosthesis-Related Infections; Retrospective Studies; Stents; Time Factors; Treatment Outcome | 2008 |
Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile; Biological Availability; Cephalexin; Cholestasis; Chromatography, High Pressure Liquid; Deoxycytidine; Gemcitabine; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Intestinal Absorption; Lipopolysaccharides; Male; Nucleoside Transport Proteins; Rats; Rats, Sprague-Dawley; Ribavirin; Ribonucleosides | 2011 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Gemcitabine; Heart Failure; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Stents; Survivors; Tegafur; Uracil | 2004 |
[Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Brachytherapy; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholestasis; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hepatic Duct, Common; Humans; Jejunostomy; Neoadjuvant Therapy; Palliative Care; Photochemotherapy; Radiotherapy, Adjuvant; Stents; Survival Rate | 2006 |